Shares of UnitedHealth Group Inc (NYSE:UNH) have been assigned an average rating of “Buy” from the twenty-seven brokerages that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and twenty-four have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $223.82.

Several research analysts recently issued reports on the company. Jefferies Group restated a “buy” rating and set a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, December 1st. Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $219.00 to $246.00 and gave the stock an “outperform” rating in a research report on Friday, December 1st. Cantor Fitzgerald restated a “buy” rating and set a $235.00 price objective on shares of UnitedHealth Group in a research report on Monday, December 25th. Finally, ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th.

In other news, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at approximately $43,310,879.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Michele J. Hooper sold 5,000 shares of the company’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the sale, the director now owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 34,630 shares of company stock valued at $7,669,416. Insiders own 0.89% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the company. Blue Chip Partners Inc. purchased a new stake in UnitedHealth Group during the 2nd quarter worth $110,000. Kings Point Capital Management boosted its position in UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares during the period. Bruderman Asset Management LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth $121,000. Institutional investors and hedge funds own 86.01% of the company’s stock.

Shares of UnitedHealth Group (NYSE:UNH) traded down $2.31 during trading on Thursday, hitting $220.46. The company had a trading volume of 2,274,987 shares, compared to its average volume of 2,669,704. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group has a 1 year low of $156.09 and a 1 year high of $231.77. The firm has a market cap of $215,879.17, a P/E ratio of 24.44, a P/E/G ratio of 1.65 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the previous year, the firm posted $2.17 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group will post 9.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s payout ratio is 33.26%.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/brokerages-set-unitedhealth-group-incorporated-unh-pt-at-224-13/1770172.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.